Carrilizumab Combined With White Purple for Squamous Cell Carcinoma of Skin

NCT05886140 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

24

Enrollment

OTHER_GOV

Sponsor class

Conditions

Squamous Cell Carcinoma of the Skin

Interventions

DRUG: Carrilizumab with albumin-binding paclitaxel

Sponsor

Henan Cancer Hospital